MAIA Biotechnology Inc (MAIA)

2.09 +0.05 (+2.45%) USD  |  NYAM  |  Dec 27, 16:00
2.09 0.00 (0.00%) After-Hours: 20:00
More

MAIA Biotechnology Research and Development Expense (Quarterly): 2.667M for Sept. 30, 2024

Research and Development Expense (Quarterly) Chart

View Research and Development Expense (Quarterly) for MAIA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

View Research and Development Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Quarterly) Benchmarks

View Research and Development Expense (Quarterly) Benchmarks
Start Trial
Emergent BioSolutions Inc 13.80M
Regeneron Pharmaceuticals Inc 1.272B
Aspira Womens Health Inc 0.908M
NovaBay Pharmaceuticals Inc 0.004M
Palatin Technologies Inc 5.744M